has received funding from the National Institutes of Health to search for biomarkers for amyotrophic lateral sclerosis (ALS), commonly called Lou Gehrig's disease. Peter H. King, M.D., professor in theDepartment of Neurology, ...
No comment yet.
Sign up to comment